EA200000860A1 - Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) - Google Patents

Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)

Info

Publication number
EA200000860A1
EA200000860A1 EA200000860A EA200000860A EA200000860A1 EA 200000860 A1 EA200000860 A1 EA 200000860A1 EA 200000860 A EA200000860 A EA 200000860A EA 200000860 A EA200000860 A EA 200000860A EA 200000860 A1 EA200000860 A1 EA 200000860A1
Authority
EA
Eurasian Patent Office
Prior art keywords
variants
options
bacterial infection
polynucleotides
polypeptide
Prior art date
Application number
EA200000860A
Other languages
English (en)
Russian (ru)
Inventor
Мартин Бойе
Бернар Р. Бродор
Дени Мартин
Клеман Риу
Хосе Хамель
Изабель Шарльбуа
Original Assignee
Байокем Фармэ Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Байокем Фармэ Инк. filed Critical Байокем Фармэ Инк.
Publication of EA200000860A1 publication Critical patent/EA200000860A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EA200000860A 1998-02-20 1999-02-17 Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты) EA200000860A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20
PCT/CA1999/000114 WO1999042588A2 (en) 1998-02-20 1999-02-17 Group b streptococcus antigens

Publications (1)

Publication Number Publication Date
EA200000860A1 true EA200000860A1 (ru) 2001-10-22

Family

ID=22125658

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000860A EA200000860A1 (ru) 1998-02-20 1999-02-17 Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)

Country Status (22)

Country Link
US (4) US20030031682A1 (enExample)
EP (3) EP1054971B1 (enExample)
JP (2) JP4637350B2 (enExample)
KR (1) KR100771148B1 (enExample)
CN (2) CN1268745C (enExample)
AP (1) AP2000001886A0 (enExample)
AT (1) ATE347600T1 (enExample)
AU (1) AU2505999A (enExample)
CA (1) CA2321106C (enExample)
CZ (1) CZ301056B6 (enExample)
DE (1) DE69934299T2 (enExample)
EA (1) EA200000860A1 (enExample)
ES (2) ES2278436T3 (enExample)
HU (1) HU228497B1 (enExample)
ID (1) ID27482A (enExample)
IL (3) IL137921A0 (enExample)
NO (2) NO330491B1 (enExample)
NZ (1) NZ529854A (enExample)
OA (1) OA11686A (enExample)
TR (1) TR200002437T2 (enExample)
WO (1) WO1999042588A2 (enExample)
ZA (1) ZA991325B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID27482A (id) 1998-02-20 2001-04-12 Iaf Biochem Int Antigen streptococcus kelompok b
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
CA2337102A1 (en) * 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
KR100790653B1 (ko) 1998-12-22 2007-12-31 마이크로싸이언스 리미티드 유전자와 단백질들, 및 그들의 사용
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
AU7076100A (en) * 1999-08-25 2001-03-19 Med Immune, Inc. Homologs of a pneumococcal protein and fragments for vaccines
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
DE60136356D1 (de) 2000-06-12 2008-12-11 Univ Saskatchewan Chimäres GapC Protein aus Streptococcus und dessen Verwendung zur Impfung und Diagnostik
WO2001096381A2 (en) * 2000-06-12 2001-12-20 University Of Saskatchewan IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
AU2002210301A1 (en) 2000-10-13 2002-04-22 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP1328543B1 (en) 2000-10-27 2009-08-12 Novartis Vaccines and Diagnostics S.r.l. Nucleic acids and proteins from streptococcus groups a & b
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
WO2003068813A2 (en) * 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
JP4875490B2 (ja) 2003-07-31 2012-02-15 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
US20090317420A1 (en) 2004-07-29 2009-12-24 Chiron Corporation Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
EP1807446A2 (en) 2004-10-08 2007-07-18 Novartis Vaccines and Diagnostics, Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
CN104292312A (zh) 2007-12-21 2015-01-21 诺华股份有限公司 链球菌溶血素o的突变形式
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection
CN115057944B (zh) * 2022-06-24 2025-06-24 南京农业大学 一种针对所有gbs血清型的多表位亚单位疫苗

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US5302386A (en) 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
WO1994021685A1 (en) 1993-03-19 1994-09-29 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US5595740A (en) 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
WO1996013516A1 (en) * 1994-11-01 1996-05-09 Kirin Beer Kabushiki Kaisha Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
ID27482A (id) 1998-02-20 2001-04-12 Iaf Biochem Int Antigen streptococcus kelompok b
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
CA2337102A1 (en) 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
DE69940439D1 (de) 1998-12-21 2009-04-02 Medimmune Inc Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
NZ512574A (en) 1998-12-23 2004-03-26 Iaf Biochem Int Novel streptococcus antigens useful as vaccines
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
WO2003068813A2 (en) 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen

Also Published As

Publication number Publication date
NO20004161L (no) 2000-10-19
KR20010034518A (ko) 2001-04-25
JP2009242403A (ja) 2009-10-22
KR100771148B1 (ko) 2007-10-29
CA2321106A1 (en) 1999-08-26
ATE347600T1 (de) 2006-12-15
JP4637350B2 (ja) 2011-02-23
IL190018A0 (en) 2008-08-07
ES2540281T3 (es) 2015-07-09
CA2321106C (en) 2013-07-23
EP2280072A3 (en) 2012-06-06
NO20101682L (no) 2000-10-19
EP1757697A2 (en) 2007-02-28
IL137921A0 (en) 2001-10-31
WO1999042588A3 (en) 2000-03-23
CZ301056B6 (cs) 2009-10-29
HU228497B1 (en) 2013-03-28
TR200002437T2 (tr) 2000-11-21
EP1757697A3 (en) 2007-05-30
EP1054971B1 (en) 2006-12-06
NO330491B1 (no) 2011-05-02
DE69934299T2 (de) 2007-07-05
NZ529854A (en) 2005-08-26
IL137921A (en) 2008-06-05
US20030031682A1 (en) 2003-02-13
ES2278436T3 (es) 2007-08-01
AU2505999A (en) 1999-09-06
ZA991325B (en) 1999-08-20
EP2280072A2 (en) 2011-02-02
US20030228323A1 (en) 2003-12-11
US20110182923A1 (en) 2011-07-28
CN1297482A (zh) 2001-05-30
NO20004161D0 (no) 2000-08-18
CN1268745C (zh) 2006-08-09
US7914794B2 (en) 2011-03-29
US8226953B2 (en) 2012-07-24
DE69934299D1 (de) 2007-01-18
EP1054971A2 (en) 2000-11-29
CN1944652A (zh) 2007-04-11
HUP0102304A3 (en) 2008-03-28
IL190018A (en) 2011-07-31
AP2000001886A0 (en) 2000-09-30
CZ20003054A3 (cs) 2001-03-14
OA11686A (en) 2005-01-12
JP2002507396A (ja) 2002-03-12
EP2280072B1 (en) 2015-03-25
WO1999042588A2 (en) 1999-08-26
US20130095498A1 (en) 2013-04-18
US8580262B2 (en) 2013-11-12
ID27482A (id) 2001-04-12
HUP0102304A1 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
EA200000860A1 (ru) Выделенный полинуклеотид (варианты), полинуклеотид (варианты), вектор (варианты), клетка-хозяин (варианты), выделенный полипептид (варианты), способ его получения (варианты), вакцинная композиция (варианты), способ терапевтического или профилактического лечения стрептококковой бактериальной инфекции у животного (варианты), применение (варианты)
EA200201280A1 (ru) Стрептококковые антигены
EA200100565A1 (ru) Новые стрептококковые антигены
EE200200709A (et) Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine
DK0950068T3 (da) Kollagen-bindende proteinsammensatninger og fremgangsmade til anvendelse
ZA965482B (en) Novel antigen.
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
NO329875B1 (no) Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer.
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
SG144692A1 (en) Antigenic proteins of shrimp white spot syndrome virus and uses thereof
DK0909323T3 (da) Helicobacter pylori-bakterioferritin
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
AU1540795A (en) Diagnosis and treatment of infections due to streptococci and enterococci
CA2284110A1 (en) An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
RU2000131225A (ru) Белки moraxella catarrhalis
DE60035485D1 (de) IDENTIFIZIERUNG VON SPEZIFISCHEN DIFFERENZIELL EXPRIMIERTEN ANTIGENEN AUS MYCOBACTERIUM UND MEDIZINISCHE VERWENDUNG DER MYCOBAKTERIUMPROTEINE Rv0068 UND Rv3407
NO923828L (no) Polypeptider, nyttige til diagnose av og behandling mot mycoplasma-infeksjoner hos dyr
EP1950302A3 (en) Streptococcus antigens
HUP9900766A2 (hu) Helicobacter pylorival kapcsolatos nukleinsav- és aminosavszekvenciák diagnosztikumokhoz és gyógyszerekhez
RU97115365A (ru) Антиген helicobacter pylori
RU92004487A (ru) Днк, полипептид, вакцина, вектор, микроорганизм, клетка насекомого, реагент, способы лечения и профилактики, способ обнаружения антигенов